Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Shanghai Journal of Preventive Medicine ; (12): 488-493, 2023.
Article in Chinese | WPRIM | ID: wpr-978414

ABSTRACT

ObjectiveTo describe the neuropsychological development screening of 0‒2 years in Tongzhou from 2017 to 2021 so as to understand the status and trend of developmental delay (DD). MethodsAnnual report data of 21 community health service centers in Tongzhou District from 2017 to 2021 were clustered, Chi square test was used to analyze the differences in positive rate and DD rate of children aged 0‒2 years with different ages and household registration, and Chi square trend test was used to analyze the linear trend of each age group and household registration. The Gesell test results in 762 children with developmental delay were analyzed, and Chi square test was used to compare the age distribution differences in gross motor, fine motor, language and personal-social behaviors. ResultsThe DD rate of children aged 0‒2 years in 2017‒2021 was 0.43%. A decreasing trend of DD rate in the 0‒ age group was observed (χ2=14.135, P<0.001), while an increasing trend of DD rate in the 1‒ and <3 age groups was observed (χ2=5.375, P=0.020; χ2=5.558, P=0.018). The DD rate of children aged 0‒2 years with Beijing household registration was higher (χ2=12.504, P<0.001). The DD rate of gross motor was the highest in the 0‒ age group (64.60%), the DD rate of language was the highest in the <3 age group (85.97%), and a statistically significant difference of gross motor and language was separately found in the three age groups (χ2=183.061, P<0.001; χ2=78.450, P<0.001). ConclusionAge and Beijing household registration are the influencing factors of DD for children aged 0‒2, and 0‒ years and <3 years are the critical periods for guidance and intervention to promote the development of gross motor and language abilities.

2.
Chinese Pharmacological Bulletin ; (12)2003.
Article in Chinese | WPRIM | ID: wpr-562346

ABSTRACT

Aim To investigate the effects of leptin on ?1(Ⅰ) collagen mRNA expression and protein production, and the roles of Janus kinase/signal transducers and activators transcription(JAK/STAT) signaling transduction pathway in increased ?1(Ⅰ) collagen mRNA expression stimulated by leptin in activated hepatic stellate cells(HSCs).Methods Firstly, ?1(Ⅰ) collagen mRNA expression and protein production as well as JAK1 and STAT3 phosphorylation induced by leptin at different doses in a human HSC cell line, LX-2 were determined by RT-PCR, ELISA, and Western-blot.Secondly, the effects of JAK1 inhibitor AG490 on JAK1 phosphorylation and ?1(Ⅰ) collagen mRNA expression stimulated by leptin were detected by Western blot and RT-PCR. Thirdly, the roles of AG490 and transfection with STAT3 antisense oligonucleotide(STAT3-ASON) in STAT3 phosphorylation after leptin were detected by Western blot. Finally, the effect of transfection with STAT3-ASON on ?1(Ⅰ) collagen mRNA expression after leptin was measured by RT-PCR.Results Leptin increased ?1(Ⅰ) collagen mRNA expression and protein production in a dose-dependent manner in LX-2, reaching a maximal level at 80 ?g?L-1 leptin. In addition, phosphorylation of JAK1 and STAT3 after leptin exhibited a time-dependent effect. Besides, JAK1 inhibitor AG490 completely blocked JAK1 and STAT3 phosphorylation and increased in ?1(Ⅰ) collagen gene expression after leptin in LX-2. Transfection with STAT3-ASON blocked STAT3 phosphorylation and increased ?1(Ⅰ) collagen mRNA by leptin in LX-2.Conclusion Leptin had a direct action on liver fibrogenesis by stimulating ?1(Ⅰ) collagen mRNA expression and protein production in activated HSC, and JAK/STAT signaling transduction pathway was involved in the process. JAK1 inhibitor AG490 and transfection with STAT3-ASON blocked the transduction pathway effectively in LX-2. Leptin may be an important factor in the development of hepatic fibrosis. Activated JAK1 and STAT3 signaling in human HSC line provided a novel molecular target for therapeutic intervention of liver fibrosis.

SELECTION OF CITATIONS
SEARCH DETAIL